We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$517B
AUM Growth
+$27.6B
Cap. Flow
-$8.37B
Cap. Flow %
-1.62%
Top 10 Hldgs %
19.4%
Holding
4,590
New
277
Increased
1,772
Reduced
2,129
Closed
201

Top Sells

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$692M
2
LIN icon
Linde
LIN
+$624M
3
MDT icon
Medtronic
MDT
+$527M
4
GS icon
Goldman Sachs
GS
+$340M
5
MSFT icon
Microsoft
MSFT
+$301M

Sector Composition

Rank Sector Weight
1 Technology 25.11%
2 Healthcare 13.18%
3 Financials 12.45%
4 Consumer Discretionary 10.8%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRAW icon
4351
Traws Pharma
TRAW
$8.53M
-300
Closed -$112K
MTVA
4352
MetaVia Inc
MTVA
$7.54M
-7
Closed -$84K
DVLT
4353
Datavault AI
DVLT
$265M
-2
Closed -$82K
ATXI
4354
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
-13
Closed -$91K
ENLC
4355
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
-297,642
Closed -$1.28M
VCNX
4356
DELISTED
Vaccinex, Inc. Common Stock
VCNX
-85
Closed -$54K
ORGS
4357
DELISTED
Orgenesis Inc. Common Stock
ORGS
-4,957
Closed -$284K
IAUF
4358
DELISTED
iShares Gold Strategy ETF
IAUF
-4,725
Closed -$248K
CNTG
4359
DELISTED
Centogene N.V. Common Shares
CNTG
-16,190
Closed -$196K
CALB
4360
DELISTED
California BanCorp Common Stock
CALB
-20,847
Closed -$372K
GRTX
4361
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
-32,303
Closed -$285K
NMRD
4362
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
-15,280
Closed -$117K
TBLT
4363
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
-5
Closed -$44K
NETI
4364
DELISTED
Eneti Inc.
NETI
-23,519
Closed -$495K
ARCE
4365
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
-272,539
Closed -$6.91M
CORR
4366
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
-55,021
Closed -$389K
PTRS
4367
DELISTED
Partners Bancorp Common Stock
PTRS
-26,739
Closed -$196K
KBNT
4368
DELISTED
Kubient, Inc. Common Stock
KBNT
-14,755
Closed -$108K
NOVN
4369
DELISTED
Novan, Inc. Common Stock
NOVN
-6,828
Closed -$107K
NYMX
4370
DELISTED
Nymox Pharmaceutical Corp
NYMX
-103,404
Closed -$230K
STSA
4371
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
-39,472
Closed -$234K
BLCM
4372
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-13,308
Closed -$50K
LMST
4373
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
-15,710
Closed -$249K
LHDX
4374
DELISTED
Lucira Health, Inc. Common Stock
LHDX
-23,935
Closed -$290K
MTCR
4375
DELISTED
Metacrine, Inc. Common Stock
MTCR
-11,090
Closed -$69K

Similar funds

Bank of New York Mellon's Q2 2021 Portfolio in Review

As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
  • Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
  • Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
  • Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
  • Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
  • Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
  • Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.